• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Labcorp Goes on Spring Spending Spree

Labcorp Goes on Spring Spending Spree

by Ron Shinkman | Jun 4, 2024 | Deals-lir, Essential, Lab Industry Advisor

Most of Invitae's employees will be hired by Labcorp, which expects the deal to add about $275 million in annual revenue

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Dx Deals: Collaboration Takes Psoriasis Testing to New Level

Dx Deals: Collaboration Takes Psoriasis Testing to New Level

by Ron Shinkman | Mar 28, 2024 | Deals-lir, Essential, Lab Industry Advisor

Partnership between Mindera and PBM aims to optimize treatment matches for the disorder, as some drugs cost nearly six figures annually

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Dx Deals: Quest and Labcorp Move beyond Laboratory Testing

Dx Deals: Quest and Labcorp Move beyond Laboratory Testing

by Ron Shinkman | Mar 5, 2024 | Deals-lir, Essential, Lab Industry Advisor

Both companies have made recent moves to diversify further.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Dx Deals Roundup: Pact Aims to Improve Prostate Cancer Detection Among Hispanic Males

Dx Deals Roundup: Pact Aims to Improve Prostate Cancer Detection Among Hispanic Males

by Ron Shinkman | Jan 30, 2024 | Deals-lir, Essential, Lab Industry Advisor

More aggressive use of artificial intelligence may mitigate issues that lead to the uneven impact of the disease on this group.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Dx Deal Roundup: Top 10 Clinical Lab M&A Deals of 2023

Dx Deal Roundup: Top 10 Clinical Lab M&A Deals of 2023

by Glenn S. Demby | Jan 9, 2024 | Deals-lir, Essential, Lab Industry Advisor

An overview of the key 2023 mergers and acquisitions in the diagnostics industry and the trends they reveal.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com